Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» TSR-011
TSR-011
TESARO Describes Initial Phase 1 Clinical Data for TSR-011 Presented at the European Cancer Congress 2013
Yahoo/GlobeNewsWire
Sun, 09/29/13 - 01:35 pm
TSR-011
pancreatic cancer
Tesaro
Scrappy Upstarts Aiming For Pfizer's Xalkori Market
Seeking Alpha
Mon, 06/3/13 - 11:29 am
Pfizer
Xalkori
Tesaro
Ariad Pharmaceuticals
AP26113
lung cancer
TSR-011